Integrin expression on CD34+cells and integrin-dependent binding of CCN1 to CD34+cells. (A) Expression of integrins on CD34+ cells was analyzed by flow cytometry using antibodies against integrins αM, β2, αV, β3, α6, and β1, respectively (filled graphs). Open graphs represent isotype controls. Cells in the histograms are gated for CD34 expression. (B) 1 × 105 CD34+ cells pretreated with 1 mM RGD peptides (RGD and GRGDSP) or left untreated were incubated with 50 ng of CCN1 for 4 hours. After centrifugation of the cells supernatants and cell pellets were subjected to Western blot analysis using antibodies against CCN1. One representative blot of 3 independent experiments is shown. (C) Immunofluorescent staining of CD34+ cells with an antibody against CCN1 in the absence or after preincubation with 1, 10, and 100 ng/mL CCN1 and/or with 1 mM RGD peptides (RGD and GRGDSP) for 30 minutes followed by several washing steps. Immunofluorescence was significantly increased compared with conditions without CCN1 (*P < .01) and significantly reduced by RGD-peptides compared with 100 μg/mL CCN1 (#P < .05). Data represent the mean (± SEM) immunofluorescence of 25 to 50 analyzed cells per condition. (D) Immunofluorescent staining of CD34+ cells in the absence (control) or after 30-minute stimulation with 1, 10, and 100 ng/mL CCN1 using antibodies against phosphorylated focal adhesion kinase (p-FAK, Ser722) or focal adhesion kinase (FAK). p-FAK-specific immunofluorescence was normalized to FAK-specific immunofluorescence. Immunofluorescence was significantly increased compared with conditions without CCN1 (*P < .01). Data represent the mean (± SEM) immunofluorescence of 25 to 50 analyzed cells per condition.